Bimuno

Bimuno
Biotechnology Developer
Founded 2004
Headquarters Jersey, Channel Islands UK
Parent Clasado BioSciences Ltd
Website http://www.bimuno.com/

Bimuno is a bio-engineered second generation Prebiotic (nutrition)[1] food supplement. The prebiotic supplement was developed by Clasado BioSciences, an international Biotechnology company based in Jersey, UK.[2]

Bimuno and The University of Reading, UK

The concept of prebiotics was first described by Glenn Gibson, (then at the Institute of Food Research, Reading) and Marcel Roberfroid (at the University Catholique Louvain, Belgium) in 1995.[3] As Professor of Food Microbiology at the University of Reading in 1999,[4] Gibson has continued his work on prebiotics, including the development of Bimuno - a prebiotic for use in humans.[5] The Bimuno development programme combined Gibson’s research on prebiotics with Professor Bob Rastall’s (Department of Food and Nutritional Sciences, 1994 – present) research on enzymic development of functional food ingredients.[6]

Bimuno Food Supplement

Bimuno is a Dietary supplement containing Galactooligosaccharides (β-Galacto-Oligosaccharide).[7]

β-Galacto-Oligosaccharide (Bimuno®) is one of a group of nutrient fibres (Oligosaccharides). Oligosaccarides feed and cultivate certain types of friendly Bacteria found in the gut.[8][9][10][11][12][13][14][15]

Bimuno Powder Ingredients

Patents and Trademarks

Bimuno's formulation, technology, production and brand positioning are all recognised and protected by worldwide patents and trademarks.[20]

Research and Development

According to the manufacturer's website, Bimuno is the result of research and development including Peer reviews and Clinical trials conducted in collaboration with the University of Reading’s Food Microbial Sciences Unit and other global research institutes.[21]

Parent Company

Clasado BioSciences is an International Biotechnology company headquartered on the island of Jersey in The Channel Islands.[22]

Clasado BioSciences researches and develops galacto-oligosaccharide (GOS) products for Food, Healthcare and Pharmaceutical companies.[23]

Clasado BioSciences are developers and manufacturers of prebiotic technologies.[26]

References

  1. ↑ "A gut feeling" (PDF). Retrieved 2015-11-16.
  2. ↑ "Clasado About Us". Retrieved 2015-11-16.
  3. ↑ "Development of a new prebiotic product (Bimuno) - from research to retail.". Retrieved 2015-11-16.
  4. ↑ "Staff Profile:Professor Glenn Gibson". Retrieved 2015-11-16.
  5. ↑ "Staff Profile:Professor Glenn Gibson". Retrieved 2015-11-16.
  6. ↑ "BIMUNO RESEARCH AND CLINICAL TRIALS". Retrieved 2015-11-16.
  7. ↑ "Case Study Contract Research:Developing a Prebiotic product" (PDF). Retrieved 2015-11-16.
  8. ↑ Bouhnik Y, Raskine L, Simoneau G, et al. (December 2004). "The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study". Am. J. Clin. Nutr. 80 (6): 1658–64. PMID 15585783.
  9. ↑ Ito M.; Deguchi Y.; Matsumoto K.; Kimura M. Onodera; Yajima T. (1993). "Influence of galactooligosaccharides on the human fecal microflora". J. Nutr. Sci. Vitaminol. 39: 635–640. doi:10.3177/jnsv.39.635.
  10. ↑ Silk DB, Davis A, Vulevic J, Tzortzis G, Gibson GR (March 2009). "Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome". Aliment. Pharmacol. Ther. 29 (5): 508–18. doi:10.1111/j.1365-2036.2008.03911.x. PMID 19053980.
  11. ↑ Vulevic J, Drakoularakou A, Yaqoob P, Tzortzis G, Gibson GR (November 2008). "Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers". Am. J. Clin. Nutr. 88 (5): 1438–46. PMID 18996881.
  12. ↑ Ben XM, Zhou XY, Zhao WH, et al. (June 2004). "Supplementation of milk formula with galacto-oligosaccharides improves intestinal micro-flora and fermentation in term infants". Chin. Med. J. 117 (6): 927–31. PMID 15198901.
  13. ↑ Boehm G, Lidestri M, Casetta P, et al. (May 2002). "Supplementation of a bovine milk formula with an oligosaccharide mixture increases counts of faecal bifidobacteria in preterm infants". Arch. Dis. Child. Fetal Neonatal Ed. 86 (3): F178–81. doi:10.1136/fn.86.3.f178. PMC 1721408Freely accessible. PMID 11978748.
  14. ↑ Fanaro S, Marten B, Bagna R, et al. (January 2009). "Galacto-oligosaccharides are bifidogenic and safe at weaning: a double-blind randomized multicenter study". J. Pediatr. Gastroenterol. Nutr. 48 (1): 82–8. doi:10.1097/MPG.0b013e31817b6dd2. PMID 19172129.
  15. ↑ Napoli JE, Brand-Miller JC, Conway P (November 2003). "Bifidogenic effects of feeding infant formula containing galacto-oligosaccharides in healthy formula-fed infants". Asia Pac. J. Clin. Nutr. 12 (Suppl.): S60.
  16. ↑ "Product description". Retrieved 2015-11-16.
  17. ↑ "Product description". Retrieved 2015-11-16.
  18. ↑ "Product description". Retrieved 2015-11-16.
  19. ↑ "Product description". Retrieved 2015-11-16.
  20. ↑ "Why Bimuno?". Retrieved 2015-11-16.
  21. ↑ Depeint; et al. (2008). "Prebiotic evaluation of a novel galactooligosaccharide mixture (B-GOS) produced by the enzymatic activity of Bifidobacterium bifidum NCIMB 41171, in healthy humans: a randomized, double-blind, crossover, placebo-controlled intervention study". American Journal of Clinical Nutrition. 87: 785–91.
  22. ↑ "Clasado About Us". Retrieved 2015-11-16.
  23. ↑ "Clasado About Us". Retrieved 2015-11-16.
  24. ↑ "Clasado About Us". Retrieved 2015-11-16.
  25. ↑ "Clasado About Us". Retrieved 2015-11-16.
  26. ↑ "Clasado About Us". Retrieved 2015-11-16.

External links

This article is issued from Wikipedia - version of the 8/23/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.